BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23057544)

  • 1. Conference scene: Latin American Pharmacogenomics and Personalized Medicine Conference.
    Suarez-Kurtz G
    Pharmacogenomics; 2012 Oct; 13(13):1449-52. PubMed ID: 23057544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics: from cell to clinic (Part 1).
    Siest G; Medeiros R; Melichar B; Stathopoulou M; Van Schaik RH; Cacabelos R; Abt PM; Monteiro C; Gurwitz D; Queiroz J; Mota-Filipe H; Ndiaye NC; Visvikis-Siest S
    Pharmacogenomics; 2014 Apr; 15(5):593-9. PubMed ID: 24798716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of Art of Cancer Pharmacogenomics in Latin American Populations.
    López-Cortés A; Guerrero S; Redal MA; Alvarado AT; Quiñones LA
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics: ethnicity, treatment and health in Latin American populations.
    Sosa-Macías M; Fricke-Galindo I; Fariñas H; Monterde L; Ruiz-Cruz ED; Molina-Guarneros J; Tarazona-Santos E; Rodrigues-Soares F; Galaviz-Hernández C; Peñas-Lledó E; Moya G; Lara-Riegos J; Terán E; Hernández I; Ramírez-Roa R; Altamirano-Tinoco C; López-López M; García-Ortiz JE; LLerena A
    Pharmacogenomics; 2023 Jun; 24(9):489-492. PubMed ID: 37529900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America.
    Sosa-Macías M; Teran E; Waters W; Fors MM; Altamirano C; Jung-Cook H; Galaviz-Hernández C; López-López M; Remírez D; Moya GE; Hernández F; Fariñas H; Ramírez R; Céspedes-Garro C; Tarazona-Santos E; LLerena A
    Pharmacogenomics; 2016 Nov; 17(16):1741-1747. PubMed ID: 27790935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in Latin America.
    Quinones LA; Lavanderos MA; Cayun JP; Garcia-Martin E; Agundez JA; Caceres DD; Roco AM; Morales JE; Herrera L; Encina G; Isaza CA; Redal MA; Larovere L; Soria NW; Eslava-Schmalbach J; Castaneda-Hernandez G; Lopez-Cortes A; Magno LA; Lopez M; Chiurillo MA; Rodeiro I; Castro de Guerra D; Teran E; Estevez-Carrizo F; Lares-Assef I
    Curr Drug Metab; 2014 Feb; 15(2):202-8. PubMed ID: 24524664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report on the pharmacogenomics and personalized medicine 2011 conference: part 1.
    Harrison N
    Pharmacogenomics; 2012 Jan; 13(2):141-5. PubMed ID: 22256866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.
    Freedman AN; Sansbury LB; Figg WD; Potosky AL; Weiss Smith SR; Khoury MJ; Nelson SA; Weinshilboum RM; Ratain MJ; McLeod HL; Epstein RS; Ginsburg GS; Schilsky RL; Liu G; Flockhart DA; Ulrich CM; Davis RL; Lesko LJ; Zineh I; Randhawa G; Ambrosone CB; Relling MV; Rothman N; Xie H; Spitz MR; Ballard-Barbash R; Doroshow JH; Minasian LM
    J Natl Cancer Inst; 2010 Nov; 102(22):1698-705. PubMed ID: 20944079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics in Latin American populations: regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disorders.
    Rodeiro I; Remírez-Figueredo D; García-Mesa M; Dorado P; LLerena A;
    Drug Metabol Drug Interact; 2012; 27(1):57-60. PubMed ID: 22718626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics in the age of personalized medicine.
    Dickmann LJ; Ware JA
    Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.
    Sipeky C; Llerena A; Manolopoulos VG; Pearson E; Mlakar V; Gozzo L; Simmaco M; Marchetti P; Re MD; Stankovic S; Meyer U; Cascorbi I; Ingelman-Sundberg M; Suarez-Kurtz G; Marc J; Katsila T; Paulmichl M; Nofziger C; Ansari M; Drago F; van Schaik RH
    Pharmacogenomics; 2019 Oct; 20(15):1063-1069. PubMed ID: 31588876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conference report: pharmacogenomics in special populations at WCP2018.
    Suarez-Kurtz G; Aklillu E; Saito Y; Somogyi AA
    Br J Clin Pharmacol; 2019 Mar; 85(3):467-475. PubMed ID: 30537134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Institutional Profile: Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicine.
    Mitropoulos K; Innocenti F; van Schaik RH; Lezhava A; Tzimas G; Kollia P; Macek M; Fortina P; Patrinos GP
    Pharmacogenomics; 2012 Mar; 13(4):387-92. PubMed ID: 22379996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Diversity in Pharmacogenetics: A Latin American Perspective.
    Suarez-Kurtz G; Parra EJ
    Adv Pharmacol; 2018; 83():133-154. PubMed ID: 29801573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy.
    Di Francia R; De Monaco A; Saggese M; Iaccarino G; Crisci S; Frigeri F; De Filippi R; Berretta M; Pinto A
    Curr Cancer Drug Targets; 2018; 18(5):499-511. PubMed ID: 28183252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments in pharmacogenetics, pharmacogenomics, and personalized medicine.
    Abad-Santos F; Aliño SF; Borobia AM; García-Martín E; Gassó P; Maroñas O; Agúndez JAG
    Pharmacol Res; 2024 Feb; 200():107061. PubMed ID: 38199278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.
    Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS
    OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implementation of pharmacogenetics.
    García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
    Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.